Sepracor Makes Peace With Barr Over Xopenex
Sepracor Inc. has reached a settlement agreement with Barr Laboratories Inc. that will put to rest nearly two years of feuding over a group of patents covering the inhaled asthma treatment...To view the full article, register now.
Already a subscriber? Click here to view full article